Federal Reserve Chairman Jerome Powell’s recent dovish remarks provided a clear signal that rate cuts are coming, easing market anxiety and fueling rallies in both cyclical and momentum-driven stocks. The 2-year Treasury yield currently sits at 3.74%, a level markets believe the Fed Funds rate should match, implying at least three rate cuts ahead. While the economy has slowed in 2025, expectations are for a gradual pickup in momentum into 2026, with the possibility of the Fed Funds rate dropping to 3% under new leadership. Investor sentiment remains mixed, with AAII showing more bearish than bullish respondents, yet margin debt has reached record highs, highlighting both optimism and risk.

On the corporate side, attention is on NVIDIA’s upcoming earnings, with consensus expecting continued strong AI-driven growth and revenue potentially topping $50 billion. Market participants are also eyeing results from URBN, ANF, GAP, and MRVL, which could provide insight into the consumer and technology sectors. Meanwhile, biotech firm VKTX is drawing interest after reporting strong weight-loss drug trial results, despite market misinterpretation of safety data. Overall, fundamentals are improving, but with stocks priced ahead of economic realities and seasonal challenges approaching, the outlook suggests both opportunities for gains and reasons for caution.

‍

‍